Application and development of nanomaterials in the diagnosis and treatment of esophageal cancer

Qianwen Xiao; Yafei Zhang; Anshun Zhao; Zhikang Duan; Jun Yao

doi:10.3389/fbioe.2023.1268454

Application and development of nanomaterials in the diagnosis and treatment of esophageal cancer

Front Bioeng Biotechnol. 2023 Nov 3:11:1268454. doi: 10.3389/fbioe.2023.1268454. eCollection 2023.

Authors

Qianwen Xiao¹, Yafei Zhang¹, Anshun Zhao¹, Zhikang Duan¹, Jun Yao¹

Affiliation

¹ Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.

Abstract

Esophageal cancer is a malignant tumor with a high incidence worldwide. Currently, there are a lack of effective early diagnosis and treatment methods for esophageal cancer. However, delivery systems based on nanoparticles (NPs) have shown ideal efficacy in real-time imaging and chemotherapy, radiotherapy, gene therapy, and phototherapy for tumors, which has led to their recent widespread design as novel treatment strategies. Compared to traditional drugs, nanomedicine has unique advantages, including strong targeting ability, high bioavailability, and minimal side effects. This article provides an overview of the application of NPs in the diagnosis and treatment of esophageal cancer and provides a reference for future research.

Keywords: anti-cancer; diagnosis; esophageal cancer; nanoparticles; treatment.

Publication types

Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was financially supported by the National Natural Science Foundation of China (82202644).